Vol. 55 (2024): Supplement 1

Invited Reviews

• Therapeutic mechanisms of glucocorticoids, their administration and chronotherapy

  Hakan Babaoğlu, Ömer Karadağ

  1-9

  • PDF

• Management of hypertension and coronary artery disease in vasculitis patients using glucocorticoids

  Sevda Aygün, Ergün Barış Kaya

  10-16

  • PDF

• Management of glucocorticoid-induced diabetes

  Seda Hanife Oğuz

  17-21

  • PDF

• Glucocorticoid toxicity index

  Sema Kaymaz Tahra, Melda Bahap Kara

  22-26

  • PDF

• Glucocorticoid doses according to tissue/organ involvement in ANCA-associated vasculitis

  Nazife Şule Yaşar Bilge

  27-29

  • PDF

• Glucocorticoids in IgA vasculitis

  Berkan Armağan

  30-32

  • PDF

• The use of glucocorticoids in Behçet’s disease

  Rabia Deniz, Cemal Bes

  33-36

  • PDF

• Why are glucocorticoids recommended at a high dose in the Takayasu arteritis guidelines?

  Gökçe Kenar Artın

  37-39

  • PDF

• Differences in glucocorticoid use in childhood vasculitis

  Dilara Ünal, Yelda Bilginer

  40-46

  • PDF

• Glucocorticoid treatment for primary and secondary central nervous system vasculitis

  Emine Uslu

  47-50

  • PDF

• Rational use of glucocorticoids during pregnancy in patients with systemic vasculitis

  Nilüfer Alpay Kanıtez

  51-53

  • PDF

• Perioperative management of patients receiving glucocorticoids in rheumatology

  Rıza Can Kardaş, Hamit Küçük

  54-58

  • PDF